Live Breaking News & Updates on Leszek Lisowski

Stay updated with breaking news from Leszek lisowski. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

4BIO Capital Strengthens Advisory Board and Investment

Press Release 4BIO Capital Strengthens Advisory Board and Investment Team Industry veteran and former CEO of Vifor Pharma Abbas Hussain and world. ....

New South Wales , City Of , United Kingdom , Natalie Johnston , Exigen Biotherapeutics , Dima Kuzmin , Abbas Hussain , Vifor Pharma , Vifor Pharma Abbas Hussain , Leszek Lisowski , Dmitry Kuzmin , Eli Lilly , Amber Fennell , University Of Sydney , Logicbio Co , Investment Team , Strengthens Advisory Board , Logicbio Co Founder Leszek Lisowski , Global President Pharmaceuticals , Logicbio Therapeutics , Sendatu Therapeutics , Associate Professor , Unit Head , Translational Vectorology Research Unit , Medical Research Institute , Viral Vector Manufacturing Facility ,

AAV Manufacturing — Overcoming the Challenges of Plasmid DNA, Upcoming Webinar Hosted by Xtalks

Toronto, ON (PRWEB) November 14, 2022 AAV manufacturing and other types of advanced therapy production are experiencing challenges associated with their ....

New South Wales , United Kingdom , Leszek Lisowski , Lisa Caproni , Vera Kovacevic , Honeycomb Worldwide Inc , Children Medical Research Institute , University Of Sydney , Vaccine Therapy , Unit Head , Medical Research Institute , Life Science , Press Release ,

DiNAQOR Announces Research Collaboration with Children's Medical Research Institute to Develop Novel, Cardiac Specific Capsids

/PRNewswire/ DiNAQOR, a genetic medicine platform company focused on addressing severe inherited cardiac diseases, today announced it has entered into a. ....

New South Wales , Laguna Hills , United States , City Of , United Kingdom , Leszek Lisowski , Johannes Holzmeister , Kellie Walsh , Eduard Ayuso , Lorel Colgin , Children Medical Research Institute , University Of Sydney , Medical Research Institute , Chief Technology Officer , Associate Professor Leszek Lisowski , Associate Professor ,

Logicbio Therapeutics (LOGC) Gets a Buy Rating from Chardan Capital

Markets
In a report released today, Geulah Livshits from Chardan Capital reiterated a Buy rating on Logicbio Therapeutics (LOGC – Research Report), with a price target of $20.00. The company’s shares closed last Tuesday at $6.10.
According to TipRanks.com, Livshits is a top 100 analyst with an average return of 78.0% and a 71.0% success rate. Livshits covers the Healthcare sector, focusing on stocks such as Iovance Biotherapeutics, Crispr Therapeutics AG, and Intellia Therapeutics.
Logicbio Therapeutics has an analyst consensus of Strong Buy, with a price target consensus of $17.00.
Logicbio Therapeutics’ market cap is currently $184.8M and has a P/E ratio of -4.50. The company has a Price to Book ratio of 3.01. ....

United Kingdom , Leszek Lisowski , Marka Kay , Geulah Livshits , Adi Barzel , Iovance Biotherapeutics , Logicbio Therapeutics Inc , Chardan Capital , Logicbio Therapeutics , Research Report , Crispr Therapeutics , Strong Buy , Bio Therapeutics , ஒன்றுபட்டது கிஂக்டம் , மார்க்கா காய் , ஆராய்ச்சி அறிக்கை , வலுவான வாங்க , உயிர் சிகிச்சை ,